How long is it advisable to continue maintenance treatment of Crohn's disease?
Katz
Jeffry A
JA
Case Western Reserve University School of Medicine, University Hospitals of Cleveland, Ohio, USA.
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D003424:Crohn Disease / Q000473:pathology / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D012074:Remission Induction; D055502:Secondary Prevention; D012720:Severity of Illness Index; D013997:Time Factors
D000893:Anti-Inflammatory Agents